Zacks Investment ResearchFri, 20 Mar 2026 17:01:25 GMTProtagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's WhyPTGX-0.27%
Zacks Investment ResearchFri, 20 Mar 2026 14:06:11 GMTProtagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?PTGX-0.27%
Seeking AlphaWed, 18 Mar 2026 19:52:21 GMTProtagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment TranscriptPTGX-0.27%
